Myocardial blood flow reserve on PET MPI is associated with all-cause mortality and can identify patients who re- ceive a survival benefit with early revascularization compared to medical therapy.
In this paper, the authors describe a more contemporary application of viability testing that is founded on the alternative concept that the main goal of surgical revascularization is to prevent further damage by protecting the residual viable myocardium from subsequent acute coronary events.
Pre-treatment 18-FDG myocardial uptake was a predictor of clinical response and echocardiographic response response to immunosuppression in patients with cardiac sarcoid.
In a large population of matched pharmacologic stress patients, myocardial perfusion PET was superior to SPECT in image quality, interpretive certainty, and diagnostic accuracy.